All trademarks used under licence. © 2017 Purdue Pharma 575 Granite Court Pickering, Ontario L1W 3W8 | www.purdue.ca | Policies and Legal | Contact Us 1-800-387-5349
Purdue Pharma Canada is a member of Innovative Medicines Canada (IMC).
It is not recommended that any product mentioned on this website be used in a manner that is inconsistent with its Product Monograph.
Purdue Pharma Canada supports the development of consensus guidelines in professional practice such as the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain and the CDC Guideline for Prescribing Opioids for Chronic Pain. Accordingly, aspects of relevant guidelines have been excerpted or adapted for inclusion in this presentation solely for awareness and discussion. Purdue Pharma Canada does not produce professional practice guidelines. Interpretation and/or modification of any practice guideline is the responsibility of the healthcare professional and is done so at his/her discretion.
Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain. Canada: National Opioid Use Guideline Group (NOUGG); 2010 [cited 2014 Nov 2]. Available from: http://nationalpaincentre.mcmaster.ca/opioid/
Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1-49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1.